Skip to main content
Equibles

BANK OF AMERICA CORP /DE/

Bank

Position in HUMA — Humacyte, Inc.

CIK 70858 CHARLOTTE, NC
Back to HUMA Full portfolio

Position in HUMA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$451,301
+$210,862 QoQ
Shares Held
578,592
+46.1% QoQ
Ownership
0.208%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 163 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in HUMA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. HUMA ranks #248 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,039,178 $1,509,650,884
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,291,053 $805,023,185
3 CYTK
Cytokinetics Inc
 4,635,709 $394,916,048
4 ARGX
Argenx SE
 400,234 $371,325,094
5 ALNY
Alnylam Pharmaceuticals, Inc.
 994,476 $299,367,107
6 JAZZ
Jazz Pharmaceuticals plc
 1,136,091 $273,763,844
7 TVTX
Travere Therapeutics, Inc.
 4,568,341 $259,527,450
8 RPRX
Royalty Pharma plc
 4,149,422 $232,658,090

All Filings in HUMA

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $451,301 578,592
2026-03-31 $240,439 396,113
2025-12-31 $434,569 452,208
2025-09-30 $836,954 481,009
2025-06-30 $1,051,935 503,319
2025-03-31 $1,535,871 900,805
2024-12-31 $3,016,460 597,319
2024-09-30 $1,249,018 229,599
2024-06-30 $1,061,509 221,148
2024-03-31 $122,431 39,367
2023-12-31 $227,145 79,981
2023-09-30 $156,970 53,574
2023-06-30 $34,625 12,107
2023-03-31 $109,134 35,319
2022-12-31 $239,176 113,354
2022-09-30 $148,092 45,427
2022-06-30 $236,467 73,666
2022-03-31 $168,762 23,904
2021-12-31 $49,930 6,887
2021-09-30 $40,658 3,502